NIH-funded research NIH-funded research

Understanding how bacteria adapt to antibiotics at a single-cell level

Official title: Deciphering the genetic regulation of bacterial heterogeneity in response to antibiotic stress using single-cell transcriptomics

Funded at St. Jude Children's Research Hospital · NIH-11020186 · Data updated 2026-11-12

This study looks at how different types of bacteria react to antibiotics, hoping to find out why some bacteria can resist treatment, which could help doctors create better ways to fight infections and improve patient care.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSt. Jude Children's Research Hospital
NIH-funded
Lab location1 site (Memphis, United States)
Project startJanuary 1, 2025
Project endNovember 30, 2029
Funding year2025
Award (this year)$462,500
NIH project number1R35GM157243-01
Project IDNIH-11020186 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients suffering from bacterial infections that are difficult to treat due to antibiotic resistance.

Less likely to help

Patients with viral infections or those not affected by antibiotic-resistant bacteria may not benefit from this research.

What this research studies

This research investigates how individual bacteria respond to antibiotic stress, revealing that not all bacteria react the same way. By using advanced single-cell RNA sequencing technology, the study aims to identify different subpopulations of bacteria that may be resistant to antibiotics. The goal is to uncover the genetic factors that contribute to this diversity, which could lead to new strategies for preventing antibiotic resistance. Patients may benefit from insights that could improve antibiotic treatments and reduce treatment failures.

Why it matters

Potential benefit: If successful, this research could lead to new methods for preventing antibiotic resistance, improving treatment outcomes for patients with bacterial infections.

How similar studies have gone: Other research has shown promise in understanding bacterial responses to antibiotics, but this approach using single-cell transcriptomics is relatively novel.

Where this research is happening

  • St. Jude Children's Research Hospital
    Memphis, United States
    Active

Researchers

  • Principal investigator: Ma, Peijun — St. Jude Children's Research Hospital
  • Study coordinator: Ma, Peijun

Related research

Other NIH-funded projects on the same topics.

  • Investigating frailty and aging in childhood cancer survivors

    This study is looking at childhood cancer survivors to see how they might face health challenges similar to older adults as they grow up, and it aims to find ways to help them stay strong and healthy by exploring treatments that could improve their well-being.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9890475

  • Investigating a specific type of leukemia in children caused by genetic changes.

    This study is looking at how certain proteins linked to leukemia affect kids and teens with high-risk blood cancers, and the researchers hope to find new ways to treat these conditions by learning more about how the disease works.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-9834651

  • Accessible, label-free optical imaging to reveal disease signals

    A brain-friendly, patient-centered imaging approach aims to uncover hidden disease signals in cells and tissues without labels or dyes.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11627327

  • Targeting the SCP4 pathway in acute myeloid leukemia (AML)

    Aims to uncover how the SCP4 signaling pathway drives AML and how it could be blocked to help patients.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11617813

  • Blocking cancer-causing cMYC tricks after pregnancy changes in the breast

    Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11615605

  • Targeting aberrant enhancer landscapes in pancreatic cancer

    A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.

    NIH research St. Jude Children's Research Hospital · Memphis, United States · NIH-11611138

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.